tbc-11251 has been researched along with Hypertension, Portal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cima, K; Desole, S; Graziadei, I; Kähler, CM; Vogel, W; Vogelsinger, H | 1 |
1 other study(ies) available for tbc-11251 and Hypertension, Portal
| Article | Year |
|---|---|
Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan.
Topics: Endothelin Receptor Antagonists; Humans; Hypertension, Portal; Hypertension, Pulmonary; Isoxazoles; Male; Pilot Projects; Syndrome; Thiophenes; Treatment Outcome; Young Adult | 2011 |